Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · $31.0B
After-hours $232.00+0.35%
Price
$313.0
$231.2
Jul 6, 26Oct 1, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$1.4B+10.7%
6/'26 vs prev quarter
Company Health
Market Cap$31.0B
Operating Margin+20.8%
Cash on Hand$3.3B10.7% of market cap
Free Cash Flow$794M2.6% of market cap
Short Float 4.1% · biweekly · settled 26.05.15
Among 327 Biotechnology peers
LowMedianHigh
PSR6.9xmedian 11.7xPER40.9xmedian 14.9xPBR24.4xmedian 2.1xROE+59.7%median -54.5%
